Status:
COMPLETED
Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
United States Department of Defense
Conditions:
Breast Cancer
Eligibility:
FEMALE
35-75 years
Brief Summary
The purpose of this study is to learn more about the application of transillumination measurements in the determination of breast cancer risk. The goal is to demonstrate a correlation between non-inva...
Detailed Description
X-ray generated images, such as mammograms, rely on the density of tissue within the breast. Tissue density are believed to be associated with proliferation of stroma and/or epithelium, which result i...
Eligibility Criteria
Inclusion
- Be in good health and able to provide consent
- Be between 35 and 75 years of age
- Have no personal history of breast cancer
- Have had a mammogram at The Marvelle Koffler Breast Centre at Mount Sinai Hospital within the last 12 months
Exclusion
- Have had breast biopsy
- Have had breast augmentation or reduction
Key Trial Info
Start Date :
March 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2003
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00188682
Start Date
March 1 2000
End Date
September 1 2003
Last Update
November 15 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ontario Cancer Institute, Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9